SCHEMBL2662073

SCHEMBL2662073

CC(C)(C)[C@H]1CC[C@H](N(C(=O)c2ccc(OC(F)(F)F)cc2)C2CCc3cc(C(=O)O)ccc32)CC1

nearest known ligand 0.76

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCGR P47871 18/20 0.76
GIPR P48546 13/20 0.69
GPR119 Q8TDV5 1/20 0.46
TRPM8 Q7Z2W7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2662071 1.00 GCGR (0.76) GCGRGIPRGPR119TRPM8
SCHEMBL2884133 0.88 GCGR (0.79) GCGRGIPR
SCHEMBL2884135 0.88 GCGR (0.79) GCGRGIPR
SCHEMBL2876976 0.87 GCGR (0.69) GCGRGIPRGPR119
SCHEMBL2659794 0.87 GCGR (0.69) GCGRGIPRGPR119
SCHEMBL2666538 0.84 GCGR (0.69) GCGRGIPRGPR119
SCHEMBL2661300 0.82 GCGR (0.76) GCGRGIPR
SCHEMBL2661301 0.82 GCGR (0.76) GCGRGIPR
SCHEMBL2881507 0.81 GCGR (0.76) GCGRGIPR
SCHEMBL2881502 0.81 GCGR (0.76) GCGRGIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1868985-A2 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck & Co., Inc. (US) 2007-12-26 EP disclosed
WO-2006104826-A2 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 2006-10-05 WO disclosed